GE HealthCare CEO Peter Arduini discusses the company’s strategic M&A approach at the J.P. Morgan Healthcare Conference. The recent $2.3bn acquisition of Intelerad aims to enhance GE’s imaging capabilities with AI technology. AI in healthcare is projected to reach a $19bn valuation by 2027. The deal with Intelerad aligns with GE HealthCare’s goal to simplify its CT portfolio and transition towards being a healthcare solutions provider. The company’s Q3 revenues of $5.1bn led to raised 2025 guidance. GE HealthCare aims to streamline operations and enhance precision care with strategic acquisitions.

Read more at Yahoo Finance: GE HealthCare’s CEO maintains disciplined M&A strategy